Gemcitabine plus sorafenib versus gemcitabine alone in advanced biliary tract cancer: a double-blind placebo-controlled multicentre phase II AIO study with biomarker and serum programme
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
December 2014
|
| In: |
European journal of cancer
Year: 2014, Volume: 50, Issue: 18, Pages: 3125-3135 |
| ISSN: | 1879-0852 |
| DOI: | 10.1016/j.ejca.2014.09.013 |
| Online Access: | Verlag, Volltext: http://dx.doi.org/10.1016/j.ejca.2014.09.013
|
| Author Notes: | M. Moehler, A. Maderer, C. Schimanski, S. Kanzler, U. Denzer, F.T. Kolligs, M.P. Ebert, A. Distelrath, M. Geissler, J. Trojan, M. Schütz, L. Berie, C. Sauvigny, F. Lammert, A. Lohse, M.M. Dollinger, U. Lindig, E.M. Duerr, N. Lubomierski, S. Zimmermann, D. Wachtlin, A.-K. Kaiser, S. Schadmand-Fischer, P.R. Galle, M. Woerns |
| Item Description: | Gesehen am: 13.12.2016 |
|---|---|
| Physical Description: | Online Resource |
| ISSN: | 1879-0852 |
| DOI: | 10.1016/j.ejca.2014.09.013 |